A detailed history of Mariner, LLC transactions in C4 Therapeutics, Inc. stock. As of the latest transaction made, Mariner, LLC holds 130,411 shares of CCCC stock, worth $533,380. This represents 0.0% of its overall portfolio holdings.

Number of Shares
130,411
Previous 127,879 1.98%
Holding current value
$533,380
Previous $590,000 25.93%
% of portfolio
0.0%
Previous 0.0%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$4.43 - $7.38 $11,216 - $18,686
2,532 Added 1.98%
130,411 $743,000
Q2 2024

Aug 13, 2024

SELL
$4.05 - $8.1 $639 - $1,279
-158 Reduced 0.12%
127,879 $590,000
Q4 2023

Feb 14, 2024

BUY
$1.18 - $6.03 $1,824 - $9,322
1,546 Added 1.22%
128,037 $723,000
Q3 2023

Nov 13, 2023

SELL
$1.81 - $3.89 $27,723 - $59,583
-15,317 Reduced 10.8%
126,491 $235,000
Q2 2023

Aug 11, 2023

BUY
$2.75 - $3.77 $37,988 - $52,078
13,814 Added 10.79%
141,808 $389,000
Q1 2023

May 12, 2023

SELL
$3.1 - $9.02 $288 - $838
-93 Reduced 0.07%
127,994 $402,000
Q4 2022

Feb 14, 2023

BUY
$5.42 - $10.24 $14,541 - $27,473
2,683 Added 2.14%
128,087 $756,000
Q3 2022

Nov 10, 2022

SELL
$8.03 - $12.77 $1,405 - $2,234
-175 Reduced 0.14%
125,404 $1.1 Million
Q2 2022

Aug 15, 2022

BUY
$5.06 - $26.46 $2,777 - $14,526
549 Added 0.44%
125,579 $947,000
Q1 2022

May 13, 2022

BUY
$19.99 - $33.23 $2.5 Million - $4.15 Million
125,030 New
125,030 $3.03 Million

Others Institutions Holding CCCC

About C4 Therapeutics, Inc.


  • Ticker CCCC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,913,800
  • Market Cap $200M
  • Description
  • C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 trial targeting ...
More about CCCC
Track This Portfolio

Track Mariner, LLC Portfolio

Follow Mariner, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mariner, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mariner, LLC with notifications on news.